The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Credits Debits 41,870 32,750 5,400 51,250 118,000 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries expense Rent expense Depreciation expense Utilities expense Advertising expense Totals 35,400 37,000 0 100,000 35,500 503,000 301,800 100,600 32,400 20,120 6710 710,900 710,900 The following year-end adjusting entries are required: a. Depreciation expense for the year on the equipment is $11.800. b. Salaries at year-end should be accrued in the amount of $6,440. Prepare a balance sheet as of December 31, 2021. (Amounts to be deducted should be indicated with a minus sign) WOLKSTEIN DRUG COMPANY Balance Sheet At December 31, 2021 Assets S Current assets Cash Accounts receivable Inventory Prepaid rent 41,870 32,750 51,250 5,400 5 Total current assets 131,270 Property and equipment Equipment $ 118 000 Accumulated depreciation (47200) Total assets Liabilities and Shareholders' Equity Current liabilities 70,800 202,070 s Dinarinnarmant Required information Hvivu $ 202,070 . UVUVIMUI Total assets Liabilities and Shareholders' Equity Current liabilities Accounts payable Salaries payable 37,000 6,440 ok 43,440 Total current liabilities ht nt Shareholders' equity Common stock Retained earnings Total shareholders' equity Total liabilities and shareholders' equity 100,000 35,500 ences 135,500 178,940 $